Clinical Trial Update: PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with chemotherapy as neoadjuvant treatment for stage IV ovarian cancer has completed (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer Stage IV | Phase 2 | Status: COMPLETED